Research Recommendations For Adaptive Biotechnologies Corp (ADPT): Here is What You Should Know
Adaptive Biotechnologies Corp (NASDAQ:ADPT) saw an upside of 12.50% to $5.72 after adding $0.64 on Tuesday. The 5-day average trading volume is 1,666,085 shares of the company’s common stock. It has gained $6.32 in the past week and touched a new high 2 times within the past 5 days. An average of 1,305,661 shares of […]
Views On Adaptive Biotechnologies Corporation (ADPT) From A Technical Perspective
The stock of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) decreased by -$0.09 on Tuesday to finish at $5.43, down -1.63 percent. The last five days have seen an average of 1,533,820 shares of common stock traded. 10 times new highs were reached in the current year, with a fall of -$2.21. The average number of shares traded […]
Does Adaptive Biotechnologies Corporation (ADPT) Have A Cheap Price Or Is It Risky?
The stock of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) increased by $0.51 on Tuesday to finish at $6.68, up 8.27 percent. The last five days have seen an average of 1,310,080 shares of common stock traded. 10 times new highs were reached in the current year, with a fall of -$0.96. The average number of shares traded […]
Analysts Issue Research Notes On Adaptive Biotechnologies Corporation (ADPT)
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) finished Wednesday with an addition of $0.17 to close at $6.50, an upside of 2.69 percent. An average of 1,454,500 shares of common stock have been traded in the last five days. There was a gain of $0.28 in the past week, and it reached a new high 1 time over […]
Last Week, Adaptive Biotechnologies Corporation (ADPT) Recorded A Gain Of $50.68
As of Wednesday close, Adaptive Biotechnologies Corporation’s (NASDAQ:ADPT) stock was down -$0.07, moving down -1.11 percent to $6.22. The average number of shares traded per day over the past five days has been 1,262,420 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.27 fall in that time frame. […]
